Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Q4 2025 Annual earnings

Reported February 12, 2026 · Before market open

Revenue$805.0MBeat by $10.1MDiluted EPS$2.04Beat by $0.21
Revenue estimate$794.9M
EPS estimate$1.83

Next report

Jul 23, 2026 (In 1 week)
Revenue estimate$839.7M
EPS estimate$2.08

Financials

Q4 2025

Income statement

See full
Revenue$805.0M+7.5%
Gross profit$303.9M+11.1%
Operating income$156.6M-1.9%
Net income$132.1M+1.5%
EPS (diluted)$1.82+2.2%

Balance sheet

See full
Cash & equivalents$791.3M+63.3%
Total debt$326.2M+6.8%
Total equity$3.2B+18.4%
Total assets$4.3B+17.2%

Cash flow

See full
Operating cash flow$251.1M+32.1%
CapEx$76.1M-27.5%
Free cash flow$175.0M+105%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$19.79B-16.6%
Enterprise value$19.33B-17.9%
P/E40.1×-8.1×
P/S6.4×-1.8×

Profitability

See full
Gross margin35.9%+1.4pp
Operating margin19%-0.7pp
Net margin16.1%-1.0pp
FCF margin15.3%+5.7pp

Returns & leverage

See full
Return on equity16.9%-0.9pp
Debt / equity0.1×0.0×
Current ratio3×+0.2×

Segments

By segment

See full
Proprietary Products$661.8M+7.8%

Versus estimates

Revenue

Q1 2026$844.9MBeat by $64.6M
Q4 2025$805.0MBeat by $10.1M
Q3 2025$804.3MBeat by $18.6MQ2 2025$766.2MBeat by $40.1MQ1 2025$698.0MMiss by $15.0MQ4 2024$748.8MBeat by $8.3M

Diluted EPS

Q1 2026$2.13Beat by $0.45
Q4 2025$2.04Beat by $0.21
Q3 2025$1.96Beat by $0.28Q2 2025$1.84Beat by $0.33Q1 2025$1.45Beat by $0.23Q4 2024$1.82Beat by $0.11

Ask the moment West Pharmaceutical Services reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did West Pharmaceutical Services report Q4 2025 earnings?
West Pharmaceutical Services (WST) reported Q4 2025 earnings on February 12, 2026 before market open.
What were West Pharmaceutical Services's Q4 2025 revenue and EPS?
West Pharmaceutical Services reported revenue of $805.0M and diluted EPS of $2.04 for Q4 2025.
Did West Pharmaceutical Services beat estimates in Q4 2025?
Revenue beat the consensus estimate of $794.9M by $10.1M. EPS beat the consensus estimate of $1.83 by $0.21.
How did West Pharmaceutical Services's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.5% from $748.8M a year earlier and diluted EPS grew 12.1% from $1.82.
Where can I find West Pharmaceutical Services's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000105770-26-000005) and the 10-K periodic report (0000105770-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.